CoChat

Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy

Published version of a preprint

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

Purpose: Autophagy is a critical survival pathway for cancer cells under conditions of nutrient or oxygen limitation, or cell stress. As a consequence of antiangiogenic therapy, solid tumors encounter hypoxia induction and imbalances in nutrient supply. We wished to determine the role of autophagy in protection of tumor cells from the effects of antiangiogenic therapy and chemotherapy. We examined the effect of inhibiting autophagy on hypoxic colon cancer cells in vitro and on bevacizumab- and oxaliplatin-treated mouse xenografts in vivo. Experimental Design: The autophagic response to hypoxia and DNA-damaging agents was assessed by fluorescent microscopic imaging, autophagy-related gene expression, and by electron microscopic ultrastructural analysis. Pharmacologic and molecular approaches to autophagy inhibition were taken in a panel of colon cancer cell lines. Mouse xenograft models were treated with combinations of oxaliplatin, bevacizumab, and chloroquine to assess effects on tumor growth reduction and on pharmacodynamic markers of autophagy inhibition. Results: Autophagy was induced in colon cancer models by exposure to both hypoxia and oxaliplatin. Inhibition of autophagy, either with chloroquine or by downregulation of beclin1 or of ATG5, enhanced sensitivity to oxaliplatin under normal and hypoxic conditions in a synergistic manner. Both bevacizumab and oxaliplatin treatments activate autophagy in HT29 murine xenografts. The addition of chloroquine to bevacizumab-based treatment provided greater tumor control in concert with evidence of autophagy inhibition. Conclusions: These findings implicate autophagy as a mechanism of resistance to antiangiogenic therapies and support investigation of inhibitory approaches in the management of this disease. Clin Cancer Res; 19(11); 2995–3007. ©2013 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-12-1542

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 49 references

Research works printed but not linked: 1

  1. Yoo, 2011, HIF-1alpha mediates tumor hypoxia to confer a perpetual mesenchymal phenotype for malignant progression, Sci Signal, 4, pt4

Cited by

See all 240

Metadata

Authors
Selvakumaran, M., Amaravadi, R. K., Vasilevskaya, I. A., & O'Dwyer, P. J.
Affiliations
Abramson Cancer Center (US)
Venue
Clinical Cancer Research
Published
2013-05-30
Volume
19
Issue
11
Pages
2995-3007
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2101399736
Cited by
221
References
50
Citations by year
2026: 7 · 2025: 12 · 2024: 17 · 2023: 10 · 2022: 16 · 2021: 21 · 2020: 15 · 2019: 14 · 2018: 20 · 2017: 26 · 2016: 13 · 2015: 24 · 2014: 20 · 2013: 6
FWCI
15.30
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA049820, CA-49820, R01CA158377, CA158377)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
autophagy, colon cancer, anti-angiogenic therapy, bevacizumab, oxaliplatin, chloroquine, hypoxia, drug resistance, Beclin-1, ATG5, combination therapy, tumor xenografts, chemosensitivity
MeSH terms
Bevacizumab, Beclin-1, Oxaliplatin, Animals, Antineoplastic Agents, Autophagy, Chloroquine, Colonic Neoplasms, Female, Humans, Membrane Proteins, Organoplatinum Compounds, Cell Hypoxia, Drug Resistance, Neoplasm, HT29 Cells, Angiogenesis Inhibitors, Xenograft Model Antitumor Assays, Cell Line, Tumor, Apoptosis Regulatory Proteins, Mice, Gene Knockdown Techniques, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-12-1542
The paper
Selvakumaran, M., Amaravadi, R. K., Vasilevskaya, I. A., & O'Dwyer, P. J. (2013). Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-12-1542

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.